Peptides for diagnosis and treatment of ovarian cancer
Ovarian cancer is the most deadly gynecologic malignancy, and its incidence is gradually increasing. Despite improvements after treatment, the results are unsatisfactory and survival rates are relatively low. Therefore, early diagnosis and effective treatment remain two major challenges. Peptides ha...
Main Authors: | Ling Guo, Jing Wang, Nana Li, Jialin Cui, Yajuan Su |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1135523/full |
Similar Items
-
Ovarian Cancer: Tumor-Specific Urinary Micro-Peptides Profiling as Potential Biomarkers for Early Diagnosis
by: Sulafa S. Murgan, et al.
Published: (2020-10-01) -
Cell-Penetrating Peptides in Diagnosis and Treatment of Human Diseases: From Preclinical Research to Clinical Application
by: Jing Xie, et al.
Published: (2020-05-01) -
Ovarian Cancer Targeting Phage for In Vivo Near-Infrared Optical Imaging
by: Mallika Asar, et al.
Published: (2019-11-01) -
Transcytosable Peptide-Paclitaxel Prodrug Nanoparticle for Targeted Treatment of Triple-Negative Breast Cancer
by: Longkun Wang, et al.
Published: (2023-02-01) -
Modified natriuretic peptides and their potential roles in cancer treatment
by: Mengjiao Xu, et al.
Published: (2022-02-01)